4.3 Review

The role of the tumor microenvironment in HIV-associated lymphomas

Journal

BIOMARKERS IN MEDICINE
Volume 9, Issue 5, Pages 473-482

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/bmm.15.13

Keywords

angiogenesis; HIV-related diffuse large B-cell lymphoma; Hodgkin's lymphoma; immunosurveillance; impact of highly active antiretroviral therapy; p17; Tat; tumor microenvironment

Funding

  1. NIH from the National Cancer Institute [P01 CA81538]
  2. NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER
  3. National Institute for Health Research [ACF-2014-19-001] Funding Source: researchfish

Ask authors/readers for more resources

There has been considerable interest in the role of the lymphoma microenvironment. Despite the use of highly active antiretroviral therapy (HAART), AIDS-related diffuse large-B-cell lymphoma remains common and HIV-relatedHIV-associated classical Hodgkin's lymphoma is increasing in incidence. Less is known about the impact HIV and HAART have on the lymphoma microenvironment. AIDS-related diffuse large B-cell lymphoma is highly angiogenic, demonstrates increased lymphoblastic histology, proliferation, increased activated cytotoxic T cells, reduced CD4(+) and FOXP3(+) T cells, but no differences in tumor-associated macrophages. Early initiation of HAART improves immunosurveillance, but cases without viral antigens appear able to avoid immunologic reaction. Increased T cell infiltrates seen with HAART treatment in HIV-related classical Hodgkin's lymphoma may contribute to malignant cell growth.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available